Portfolio company
Zephyrus Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops single-cell protein analysis instruments and research tools for academic, biopharmaceutical and clinical scientists conducting disease research.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Cellular Research
This company develops single-cell genetic analysis tools for academic and industrial researchers to quantify gene expression in individual cells.
Proteomics
This company develops automated benchtop instruments for multiplexed protein analysis to assist researchers in the biotechnology and pharmaceutical industries.
Atrandi Biosciences
This company develops single-cell analysis platforms and microfluidic technologies for life science researchers in genomics, screening and biological innovation.
Glyphic Biotechnologies
This company develops a single-molecule protein sequencing platform for researchers and institutions focused on biological research and drug discovery.
Glyphic Bio
This company develops a single-molecule protein sequencing platform for researchers to identify amino acids and post-translational modifications in the human proteome.
Alamar Biosciences
This company develops high-sensitivity proteomics platforms and protein biomarker detection assays for life sciences researchers and clinicians in drug development and disease research.
LUMICKS
This company develops single-molecule and cell avidity analysis instruments for academic researchers and pharmaceutical companies to study biological mechanisms and develop life-saving therapies.
Nplex Biosciences
This company develops high-throughput proteomics platforms for researchers in pharmaceutical and academic sectors to measure proteins for drug and biomarker discovery.
